These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 2319261)

  • 41. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures.
    Spits H; Yssel H; Paliard X; Kastelein R; Figdor C; de Vries JE
    J Immunol; 1988 Jul; 141(1):29-36. PubMed ID: 2454260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function.
    Smyth MJ
    J Immunol; 1991 Mar; 146(6):1921-7. PubMed ID: 2005386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD5-low expression lymphocytes in canine peripheral blood show characteristics of natural killer cells.
    Huang YC; Hung SW; Jan TR; Liao KW; Cheng CH; Wang YS; Chu RM
    J Leukoc Biol; 2008 Dec; 84(6):1501-10. PubMed ID: 18708592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck.
    Heo DS; Whiteside TL; Johnson JT; Chen KN; Barnes EL; Herberman RB
    Cancer Res; 1987 Dec; 47(23):6353-62. PubMed ID: 3315186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expansion and manipulation of natural killer cells in patients with metastatic cancer by low-dose continuous infusion and intermittent bolus administration of interleukin 2.
    Soiffer RJ; Murray C; Shapiro C; Collins H; Chartier S; Lazo S; Ritz J
    Clin Cancer Res; 1996 Mar; 2(3):493-9. PubMed ID: 9816195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenotypic and cytolytic activity of Macaca nemestrina natural killer cells isolated from blood and expanded in vitro.
    Shields LE; Sieverkropp AJ; Potter J; Andrews RG
    Am J Primatol; 2006 Aug; 68(8):753-64. PubMed ID: 16847969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
    Lai P; Rabinowich H; Crowley-Nowick PA; Bell MC; Mantovani G; Whiteside TL
    Clin Cancer Res; 1996 Jan; 2(1):161-73. PubMed ID: 9816103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generation of lymphokine-activated killer cell activity from human thymocytes.
    Ramsdell FJ; Golub SH
    J Immunol; 1987 Sep; 139(5):1446-53. PubMed ID: 2442246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peripheral blood and bone marrow immunophenotypic and functional modifications induced in acute leukemia patients treated with interleukin 2: evidence of in vivo lymphokine activated killer cell generation.
    Foa R; Guarini A; Gillio Tos A; Cardona S; Fierro MT; Meloni G; Tosti S; Mandelli F; Gavosto F
    Cancer Res; 1991 Feb; 51(3):964-8. PubMed ID: 1988139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
    J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patterns of cytokines released by peripheral blood leukocytes of normal donors and cancer patients during interleukin-2 activation in vitro.
    Dupere S; Obiri N; Lackey A; Emma D; Yannelli J; Orr D; Birch R; O'Connor TE
    J Biol Response Mod; 1990 Apr; 9(2):140-8. PubMed ID: 2111374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunomodulatory properties and toxicity of interleukin 2 in patients with cancer.
    Urba WJ; Steis RG; Longo DL; Kopp WC; Maluish AE; Marcon L; Nelson DL; Stevenson HC; Clark JW
    Cancer Res; 1990 Jan; 50(1):185-92. PubMed ID: 2293554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural killer cell function and expression of beta 7 integrin in psoriatic arthritis.
    McQueen FM; Skinner MA; Krissansen GW; Robinson E; Tan PL
    J Rheumatol; 1994 Dec; 21(12):2266-73. PubMed ID: 7535357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of light, moderate and severe bicycle exercise on lymphocyte subsets, natural and lymphokine activated killer cells, lymphocyte proliferative response and interleukin 2 production.
    Tvede N; Kappel M; Halkjaer-Kristensen J; Galbo H; Pedersen BK
    Int J Sports Med; 1993 Jul; 14(5):275-82. PubMed ID: 8365836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phenotype and function of natural killer cells in patients with bronchogenic carcinoma.
    LeFever AV; Funahashi A
    Cancer Res; 1991 Oct; 51(20):5596-601. PubMed ID: 1655257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pretreatment of human peripheral blood lymphocytes with interleukin-2 or dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assay.
    Martin-Kleiner I; Gabrilovac J
    Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):37-57. PubMed ID: 8683038
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A subset of CD16-natural killer cells without antibody-dependent cellular cytotoxicity function.
    Schubert J; Heiken H; Jacobs R; Delany P; Witte T; Schmidt RE
    Nat Immun Cell Growth Regul; 1990; 9(2):103-11. PubMed ID: 2141105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of recombinant alpha-interferon administration on peripheral blood lymphocyte subpopulations and natural killer cell activity in patients with refractory anemia with excess of blasts.
    Eliopoulos G; Coulocheri S; Vaiopoulos G; Alexandrakis M; Ganotakis E; Eliopoulos A; Yataganas X
    Nouv Rev Fr Hematol (1978); 1991; 33(1):21-4. PubMed ID: 1945821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.